AML ETO T821 Gene Rearrangement PCR Qualitative Test

Genetic Testing

AML ETO T821 Gene Rearrangement PCR Qualitative Test

KSh 18,000.00 Regular price
KSh 14,940.00 Current price
-17%

The AML ETO T821 Gene Rearrangement PCR Qualitative Test is an advanced molecular diagnostic tool designed to detect the presence of specific genetic rearrangements associated with acute myeloid leukemia (AML). This test plays a vital role in the accurate diagnosis and management of leukemia, allowing healthcare provid...

What Is the AML ETO T821 Gene Rearrangement PCR Qualitative Test?

The AML ETO T821 Gene Rearrangement PCR Qualitative Test is an advanced molecular diagnostic tool designed to detect the presence of specific genetic rearrangements associated with acute myeloid leukemia (AML). This test plays a vital role in the accurate diagnosis and management of leukemia, allowing healthcare providers, particularly oncologists, to develop targeted treatment strategies based on individual patient profiles.

Who Should Consider This Test?

Patients experiencing symptoms associated with leukemia, such as:

  • Unexplained fatigue
  • Frequent infections
  • Easy bruising or bleeding
  • Weight loss
  • Swollen lymph nodes

Additionally, individuals with risk factors such as a family history of leukemia or exposure to certain chemicals should consider this test.

What Does the Test Detect or Measure?

This test specifically measures the rearrangement of the AML ETO T821 gene, which can indicate the presence of leukemia. By using Real Time PCR technology, the test provides a qualitative analysis of genetic material, identifying whether the rearrangement is present in the patient’s sample.

Sample Requirements

The sample type required for this test is 3 mL (2 mL min.) of whole blood or bone marrow collected in a Lavender Top (EDTA) tube. It is crucial to ship the sample refrigerated and avoid freezing. Samples should be submitted on Mondays or Thursdays by 11 AM, with reports available on Wednesdays or Saturdays.

What the Results May Show

Results from the AML ETO T821 Gene Rearrangement PCR Qualitative Test will indicate whether the gene rearrangement is present or absent. A positive result may suggest the need for further diagnostic testing or immediate treatment, while a negative result can help rule out specific types of leukemia. It is essential to discuss your results with your healthcare provider for accurate interpretation and next steps.

Benefits or Clinical Value

  • Provides accurate diagnosis of specific leukemia types.
  • Guides oncologists in selecting the most effective treatment options.
  • Facilitates early detection, which can lead to better patient outcomes.
  • Non-invasive sample collection with no special preparation required.

Pricing

Test Name Current Price Regular Price
AML ETO T821 Gene Rearrangement PCR Qualitative Test KSh 14,940.00 KSh 18,000.00

Book the AML ETO T821 Gene Rearrangement PCR Qualitative Test

Contact Biopassion Diagnostics to confirm sample requirements and schedule this test.

SKU: d947bf06a885 | Category: Genetic Testing